圣诺生物：预计2025年前三季度归属于母公司所有者的净利润同比增加100.53%至145.10%

Core Viewpoint - Shengnuo Bio announced a voluntary disclosure of its performance forecast for the first three quarters of 2025, expecting a significant increase in net profit compared to the same period last year [1] Financial Performance - The company anticipates a net profit attributable to shareholders of the parent company between 114.20 million and 139.57 million yuan for the first three quarters of 2025 [1] - This represents an increase of 57.25 million to 82.63 million yuan compared to the same period last year, reflecting a year-on-year growth of 100.53% to 145.10% [1]